HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal secretion as a marker of premature rupture of amniotic membranes].

Abstract
Diagnosis of premature rupture of amniotic membranes in premature pregnancy allows to estimate dangers which threaten foetus and pregnant woman and helps to put into practice the most accurate therapeutics procedures. The aim of this study was to prove the clinical usefulness of test detecting insulin-like growth factor binding protein-1 in vaginal secretion for diagnose of premature rupture of amniotic membranes and compare the sensiviteness and specificity the above test with Gram stained vaginal smears. We examined group of 50 pregnant women between 25 and 42 week of pregnancy treated in Department of Fertility and Obstetrics Medical University of Wrocław. Pregnant women were divided into 3 groups. In each of them both tests were performed to diagnose premature rupture of amniotic membranes. Achieved scores shows that Amni Check is specific and sensitive test detecting even insignificant premature rupture of amniotic membranes and has higher sensitivity comparing with common method used until now for detection of premature rupture of amniotic membranes based on Gramm stained vaginal secretion.
AuthorsJ Woytoń, A Kłósek, M Zimmer, T Fuchs
JournalGinekologia polska (Ginekol Pol) Vol. 70 Issue 11 Pg. 809-14 (Nov 1999) ISSN: 0017-0011 [Print] Poland
Vernacular TitleInsulino podobny białkowy czynnik wzrostu-1 (IGFBP-1) w treści pochwowej jako marker przedwczesnego odpływania wód płodowych (PROM).
PMID10736957 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Insulin-Like Growth Factor Binding Protein 1
Topics
  • Adult
  • Biomarkers
  • Female
  • Fetal Membranes, Premature Rupture (diagnosis)
  • Gestational Age
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 (analysis)
  • Pregnancy
  • Vagina (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: